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Abstract
Objectives: A study was made of the effect of nonsurgical periodontal treatment upon blood glucose control in 
type 2 diabetics with periodontal disease.
Study design: A pre-post repeated measures analytical design was used, with a PubMed search of the related arti-
cles published up until December 2008.
Results: The improvement in glycosylated hemoglobin (HbA1c) after nonsurgical periodontal treatment on com-
paring the baseline (8.0290±1.5539) and final values (7.7806±1.5636) was 0.2483±0.1171, and proved statistically 
significant (p=0.042).
Conclusions: A decrease in HbA1c was observed after treatment, thus indicating improved blood glucose control 
in type 2 diabetics with periodontal disease.
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Introduction
Diabetes mellitus and periodontal disease are two high-
ly prevalent chronic disorders. 
Metabolic control of blood glucose and the preven-
tion and/or treatment of the macro- and microvascular 
complications of diabetes are the main reason leading 
diabetics to seek medical care very frequently in both 
primary care and in specialized centers. 
Authors such as Li et al. (1), Amar et al. (2), Teng et al. 
(3) and Kinane et al. (4) have related periodontal dis-
ease to systemic disorders or problems such as respira-
tory dysfunction, cardiovascular disease, low weight at 
birth, osteoporosis or diabetes mellitus. 
The relationship between diabetes and periodontal dis-
ease has been the subject of many studies. In this sense, 
there is increasing agreement that diabetes and peri-
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odontal disease exhibit a bidirectional relationship. In 
1993, Löe (5) described periodontal disease as the sixth 
complication of diabetes, after diabetic nephropathy, 
neuropathy, retinopathy, vascular disease and delayed 
healing. Soskolne et al. (6) in turn indicate that accord-
ing to data from the United States Department of Health 
and Human Services (1996), derived from a National 
Health and Nutrition Examination Survey (NHANES 
III), not only does epidemiological evidence indicate 
that periodontitis is more common in diabetic patients, 
but the prevalence of diabetes in patients with periodon-
titis is moreover significantly greater than in individuals 
without periodontal problems. 
Many studies have found diabetes to be associated with 
an increased prevalence and progression of periodontal 
disease. Other authors in turn have shown periodontal 
disease to be correlated to poorer blood glucose control 
in diabetic individuals, and to an increased risk of suf-
fering complications of diabetes.
Diabetes treatment aims to keep blood glucose within 
the recommended limits, and in this sense the presence 
of periodontitis affects blood glucose control.
The present study was carried out to evaluate the effect 
of nonsurgical periodontal treatment upon blood glucose 
control in type 2 diabetics with periodontal disease.
Material and Method
The present study comprised a pre-post repeated meas-
ures analytical design, with a PubMed search of the re-
lated articles published up until December 2008.
The study sample consisted of 31 patients: 11 males 
(35.5%) and 20 females (64.5%), with an age range of 
42-81 years (mean: 66.06%±8.73).
The inclusion criteria were: type 2 diabetes mellitus, 
inclusion in the diabetes program of the Murcia Health 
Service (Spain), age over 18 years, the absence of cog-
nitive impairment and previous periodontal treatment, 
willingness to undergo exploration and the required 
complementary tests, and the signing of informed con-
sent. We excluded patients receiving antibiotic treat-
ment or who had received such treatment in the previ-
ous month, pregnant women, fully edentulous patients 
and type 1 diabetics.
Data collection and exploration of the oral cavity were 
carried out by the same dentist. In all cases a detailed 
case history was compiled, including patient age, sex, 
disease antecedents, type of diabetes, current treatment, 
duration of the disease in years, and associated systemic 
disorders. A clinical examination of the oral cavity was 
carried out, evaluating the condition of the oral mucosa, 
the Silness and Löe plaque index, and the community 
periodontal index (CPI). As complementary tests, all 
patients were subjected to a panoramic X-ray study and 
to the determination of glycosylated hemoglobin levels 
(HbA1c).
All 31 patients presented periodontal pouches in some 
of the explored sextants. In all cases nonsurgical peri-
odontal treatment was carried out, with the extraction 
of those teeth showing excessive mobility or caries-in-
duced destruction not amenable to conservative dental 
management.
Treatment was completed in several sessions (Table 1), 
according to the needs of each individual patient, with 
an interval of 7 days between sessions.
Tartar removal was carried out in a first session, and in-
structions were provided on correct tooth brushing and 
the use of interproximal brushes (Interprox®, Dentaid, 
Spain) and dental floss. In addition, 0.12% clorhexidine 
digluconate rinses were prescribed (every 12 hours for 
15 days).
Seven days after tartar removal, the scaling and root 
planing sessions were started in combination with ul-
trasound under local anesthesia (3% mepivacaine or 
4% articaine), for a total of 1-4 sessions, depending on 
the number of affected quadrants. Whenever possible, 
two quadrants per session were completed. Following 
scaling and root planning, the periodontal pouches were 
irrigated with 0.12% clorhexidine digluconate using a 
fine-needled syringe.
Approximately 30 days after the last periodontal treat-
ment session, clinical examination of the oral cavity 
was again carried out, evaluating the condition of the 
oral mucosa, the Silness and Löe plaque index, CPI and 
HbA1c.
A descriptive analysis was made of each study variable, 
recording the corresponding distribution of frequen-
cies. The basic parameters were calculated in the case 
of quantitative variables, i.e., mean, median, quartiles, 
and minimum and maximum.
Pre- and post-treatment comparisons of means were 
First visit Treatment phase 30 days Control
Anamnesis
First exploration
Panoramic X-ray study
HbA1c
Instructions on hygiene
Tartar removal
Scaling and root planing
Extractions
Final exploration
HbA1c
Table 1. Treatment scheme.
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made with the Student t-test for paired data. The com-
parison of means for several groups was based on analy-
sis of variance (ANOVA), complemented by mean pair 
equality contrasting using the minimum significant dif-
ference method with Bonferroni correction.
The comparison of proportions and the association or 
relationship between qualitative variables in turn was 
based on the analysis of contingency tables and the 
Pearson chi-squared test, complemented by analysis of 
residues.
The relationship between quantitative variables was ex-
plored by regression / correlation analysis, calculating 
the Pearson linear correlation coefficient.
Results
Approximately one-half of the patient series had dia-
betes diagnosed 8 or more years ago, and about 25% 
had been diagnosed with the disease 20 or more years 
ago. The mean duration of the disease was 11.03±7.86 
years. A statistically significant correlation (p=0.002) 
was found between the HbA1c levels both at the start 
and end of the study, and the duration of diabetes, i.e., 
the longer the duration of the disease, the poorer blood 
glucose control, since the HbA1c levels were seen to in-
crease.
Most of the patients (71%) were being treated with oral 
antidiabetic drugs, and 25.8% of the series required the 
administration of insulin to secure metabolic control. 
In only a small proportion of cases (3.2%) was man-
agement limited to dietary measures and physical exer-
cise. Significant differences were observed in the initial 
(p=0.046) and final HbA1c levels (p=0.036) between 
the subjects receiving different types of treatment for 
diabetes. Of the 31 patients included in the study, a sin-
gle patient was well controlled by dietary measures and 
physical exercise only (HbA1c=6.5%); 8 were receiving 
insulin, with a mean HbA1c of 9.1%; and the remaining 
22 patients were treated with oral antidiabetic agents 
and presented a mean HbA1c of 7.7%. 
As regards associated disease, the most common disor-
der was arterial hypertension (in 80.6% of all subjects), 
followed by osteoarthritis (25.8%), hypercholesterolem-
ia (19.4%), osteoporosis (12.9%), stroke (9.7%), retin-
opathy (6.5%), acute myocardial infarction (6.5%) and 
chronic obstructive pulmonary disease (3.2%). Only 
6.5% of the patients had no associated diseases.
Exploration of the oral cavity showed most patients (71%) 
to have disease-free oral mucosas. The most frequent 
mucosal lesion was lichen planus (6.5% of the series). 
The initial mean plaque index was 1.6368±0.788, and 
was seen to decrease significantly to 0.7907±0.619 after 
periodontal treatment (p=0.0005). 
On processing the scores of the CPI, a component of 
the community periodontal index of treatment needs 
(CPITN), as quantitative variables, a mean value of 
3.16±0.37 was obtained for maximum CPI (defined as 
the maximum CPI score obtained in any of the explored 
sextants in each case) at initial exploration. Following 
periodontal treatment, a significant decrease was ob-
served (p=0.005), since the mean maximum CPI after 
treatment was 1.97±1.25. In order to assess improvement 
of this parameter, the above data were used to generate 
a healing index, i.e., reflecting the cases that evolved 
towards scores not indicative of periodontitis (0, 1 or 2) 
at final exploration, and an improvement index, reflect-
ing the cases that evolved towards comparatively lower 
scores:
Healing index = number of cases evolving towards 
scores indicating no periodontitis / total number of cas-
es x 100 = 14 / 31 = 45.16±17.52%.
Improvement index = number of cases evolving towards 
comparatively lower scores / total number of cases x 100 
= 18 / 31 = 58.06±17.37%.
The observed improvement (Table 2) from the initial 
or baseline (8.0290±1.5539) to the final HbA1c values 
(7.7806±1.5636) was 0.2483±0.1171, and proved statisti-
cally significant (p=0.042). The correlation coefficient 
of 0.913 (p=0.0005) between mean initial and final 
HbA1c shows the final values to be dependent upon the 
baseline values, i.e., a patient starting with low HbA1c 
values improved to the same degree as a patient starting 
from higher values.
We observed no significant relationship between the in-
itial maximum CPI score and the baseline HbA1c value. 
However, a correlation was observed between the final 
maximum CPI and the final HbA1c value (p=0.041), i.e., 
higher CPI scores were associated with higher HbA1c 
levels at the end of the study.
Mean St. dev.
St. error 
of mean
95% confidence inter-
val for the difference
T df
Sig. (two-sided)Lower Upper
Initial HbA1c – Final 
HbA1c
0.24839 0.65211 0.11712 0.00919 0.48758 2.121 30 0.042
Table 2. Reduction of HbA1c levels.
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Discussion
Diabetes mellitus and periodontal disease are two 
highly prevalent chronic disorders both in Spain and 
elsewhere. Although many studies have examined the 
bidirectional relationship between diabetes and oral 
disease, and the effects of periodontal treatment upon 
the metabolic control of diabetes, the great diversity 
of screening criteria, designs, durations of follow-up, 
types of patients or treatment protocols involved makes 
it difficult to establish comparisons.
In effect, most studies show great variability in the dura-
tion of follow-up. HbA1c estimates the mean blood glu-
cose levels in the previous 30-90 days. The period be-
tween initial HbA1c recorded on the first visit and final 
HbA1c recorded on the post-treatment control visit falls 
within this time interval, since according to the study 
protocol the first treatment varied between 3-5 weeks 
after the first visit, and 30 days after the last scaling and 
root planing session a control was programmed and the 
final HbA1c value was registered. Other authors such as 
Faria-Almeida et al. (7), Navarro et al. (8) and Grossi et 
al. (9) recorded final HbA1c 3 and 6 months after treat-
ment, while Rodrigues et al. (10), Promsudthi et al. (11) 
and Cruz et al. (12) recorded this parameter 3 months af-
ter the initial HbA1c value. In turn, O´Connell et al. (13) 
and Kiran et al. (14) obtained the value 3 months after 
treatment, while Al-Mubarak et al. (15) did so 2 months 
after therapy, Iwamoto et al. (16) one month after treat-
ment, and Stewart et al. (17) recorded final HbA1c 10 
months after the initial or baseline HbA1c value.
As regards the observed significant differences in both 
the initial and final HbA1c values depending on the type 
of diabetes treatment received, we consider such differ-
ences to be logical, since patients subjected only to dietary 
management and physical exercise tend to be individu-
als that maintain good blood glucose control without the 
need for medication. In contrast, type 2 diabetics treated 
with oral antidiabetic drugs are not controlled or present 
HbA1c values that are not close to the levels indicating 
metabolic control of the disease, and moreover tend to 
vary treatment and receive insulin therapy. However, the 
recorded improvement in HbA1c levels was independent 
of the type of treatment received for diabetes, and may be 
regarded as independent of the latter.
The treatment provided in our patient series improved 
the clinical parameters, and thus also oral health. All 
the subjects had periodontitis at the start of the study. 
Most of them (83.9%) presented a maximum CPI score 
of 3, while the rest had a score of 4. Periodontal status 
improved as a result of treatment, since 6 patients pre-
sented a maximum CPI score of 0, and 45.2% had no 
sextant with scores indicative of periodontitis. Among 
the subjects that continued to present periodontitis af-
ter treatment, none had a maximum CPI score of 4. 
The periodontitis healing and improvement indexes 
used in the statistical analysis were 45.16±17.52% and 
58.06±17.37%, respectively. The improvement between 
initial and final CPI score was statistically significant 
(p=0.005), in the same way as the improvement between 
the initial and final plaque index value (p=0.0005). 
The hypothesis that HbA1c decreases after periodontal 
treatment in diabetic individuals with periodontitis has 
been the subject of many studies, with variable results. 
In our series there were statistically significant differ-
ences (p=0.042) between the initial and final HbA1c 
values after the treatment provided, with a decrease in 
HbA1c level and thus improved metabolic control of 
blood glucose. The observed correlation coefficient of 
0.913 (p=0.0005) between mean initial and final HbA1c 
shows the final values to be dependent upon the baseline 
values, i.e., a patient starting with low HbA1c values 
improved to the same degree as a patient starting from 
higher values. Similar data in relation to reductions in 
HbA1c have been published by other authors (7-10, 13-
19), though many investigators have recorded no such 
differences in similar studies. 
Among the trials reporting reductions in HbA1c, we 
have found studies that use antibiotics (fundamentally 
local minocycline or systemic doxycycline), together 
with periodontal treatment (9,13,16,19). Other authors 
such as Promsudthi et al. who likewise used antibiotic 
treatment, failed to obtain satisfactory results (11). In 
contrast, Rodrigues et al. (10) reported good results – 
but in the group not administered antibiotics. The rest 
of the studies in the reviewed literature reporting such 
metabolic improvements did not use antibiotic treat-
ment. Thus, the role of antibiotics in reducing HbA1c 
does not seem quite clear, since similar results appear to 
be achieved with periodontal treatment in the absence 
of antibiotics. Nevertheless, most studies that use anti-
biotic treatment report significant results.
Based on the maximum CPI score for diagnosing the 
cases of periodontitis, we found that at baseline (i.e., 
before starting periodontal treatment), all the patients 
had periodontal pouches. Under these circumstances, 
no correlation to the initial HbA1c levels was observed. 
However, after treatment some patients continued to 
have periodontitis while others did not. Under these cir-
cumstances a positive correlation was found between 
the final maximum CPI scores and HbA1c levels, i.e., 
higher CPI scores were associated with higher HbA1c 
levels at the end of the study. Similar results have been 
published by other authors (20). In our opinion, the initial 
situation in which all patients had periodontal pouches 
did not allow us to identify this correlation. Lastly, on 
contrasting the improvement in maximum CPI score 
with the improvement in HbA1c levels after treatment, 
the mentioned correlation disappeared – thus indicating 
that improvement occurred in all cases regardless of the 
degree of periodontal involvement.
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Conclusions
The following conclusions can be drawn from the 
present study:
1. The HbA1c levels are correlated to the duration of the 
disease and to the type of treatment provided for type 2 
diabetes mellitus.
2. The HbA1c levels are correlated to periodontal health 
status after treatment in type 2 diabetics.
3. Following nonsurgical periodontal treatment, a de-
crease in HbA1c is observed, thus indicating improved 
blood glucose control in type 2 diabetics.
4. Improvement in the HbA1c levels is obtained regard-
less of the duration of the disease and the treatment pro-
vided for type 2 diabetes mellitus.
5. Improvement in the HbA1c levels of type 2 diabetics 
after periodontal treatment is obtained regardless of the 
degree of periodontal involvement at baseline.
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